Jewell Christopher M
SEC insider (Form 3/4/5 filer). CIK 0002000226. Chief Scientific Officer at Cartesian Therapeutics, Inc. (RNAC). 10 reported Form 4/5 transactions since Sep 2024; latest on Jan 10, 2025. Located in FREDERICK, MD.
Companies Jewell Christopher M has filed insider reports for
- Cartesian Therapeutics, Inc. (RNAC): Officer, Chief Scientific Officer
Jewell Christopher M
CIK: 0002000226
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cartesian Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jan 10, 2025RNAC
Cartesian Therapeutics, Inc.
ExerciseDirect9K shares at avg. $3.23$29K - Jan 6, 2025RNAC
Cartesian Therapeutics, Inc.
SaleDirect1.3K shares at avg. $16.83$22K - Jan 3, 2025RNAC
Cartesian Therapeutics, Inc.
SaleDirect1.3K shares at avg. $16.72$21K - Jan 2, 2025RNAC
Cartesian Therapeutics, Inc.
AwardDirect16.1K shares- - Nov 20, 2024RNAC
Cartesian Therapeutics, Inc.
ExerciseDirect14K shares at avg. $3.23$45K - Nov 15, 2024RNAC
Cartesian Therapeutics, Inc.
SaleDirect16.1K shares at avg. $17.06$274K - Nov 15, 2024RNAC
Cartesian Therapeutics, Inc.
ExerciseDirect16.1K shares at avg. $3.23$52K - Nov 14, 2024RNAC
Cartesian Therapeutics, Inc.
SaleDirect17.5K shares at avg. $17.02$298K - Nov 14, 2024RNAC
Cartesian Therapeutics, Inc.
SaleDirect18.6K shares at avg. $16.34$303K - Nov 14, 2024RNAC
Cartesian Therapeutics, Inc.
ExerciseDirect36.1K shares at avg. $3.23$116K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 10, 2025 | RNAC Cartesian Therapeutics, Inc. | Exercise | 9,000 | $3.23 | $29,070 | Direct |
| Jan 6, 2025 | RNAC Cartesian Therapeutics, Inc. | Sale | 1,286 | $16.83 | $21,646 | Direct |
| Jan 3, 2025 | RNAC Cartesian Therapeutics, Inc. | Sale | 1,264 | $16.72 | $21,136 | Direct |
| Jan 2, 2025 | RNAC Cartesian Therapeutics, Inc. | Award | 16,100 | - | $0 | Direct |
| Nov 20, 2024 | RNAC Cartesian Therapeutics, Inc. | Exercise | 14,000 | $3.23 | $45,220 | Direct |
| Nov 15, 2024 | RNAC Cartesian Therapeutics, Inc. | Sale | 16,065 | $17.06 | $274,093 | Direct |
| Nov 15, 2024 | RNAC Cartesian Therapeutics, Inc. | Exercise | 16,065 | $3.23 | $51,890 | Direct |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | Sale | 17,500 | $17.02 | $297,824 | Direct |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | Sale | 18,550 | $16.34 | $303,126 | Direct |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | Exercise | 36,050 | $3.23 | $116,442 | Direct |
1-10 of 10 transactions